This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America

Register now! The event starts in:

  • 00
  • 00
  • 00
  • 00
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

MedGene Therapeutics


MedGene Therapeutics, Inc. is a cell and gene therapy start-up company (late pre-clinical stage) based in Gaithersburg, MD. We use modified CD8 T cells to battle cancer, with 2 innovations that will 1) be less burden to the patient, and 2) propel T cell therapy to success against solid tumors. Our company was founded in 2016 when our founder, orthopedic surgeon Yong H. Park, MD, began to explore opportunities for medical impact on a greater scale. While living in the DC area, he began work on NIH-patented T cell technologies. In 2018, he partnered with immunologist Rho H. Seong, PhD from Seoul National University, for validation studies. The two formed an immediate connection that ultimately led to a company partnership.